

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * sarcomere organization (GO:0045214) | 9.65153495 |
| 2 | cardiac myofibril assembly (GO:0055003) | 9.42161882 |
| 3 | cardiac chamber formation (GO:0003207) | 8.43479402 |
| 4 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.78979532 |
| 5 | * myofibril assembly (GO:0030239) | 7.54807194 |
| 6 | cardiac ventricle formation (GO:0003211) | 7.49473562 |
| 7 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.29437773 |
| 8 | cardiac muscle contraction (GO:0060048) | 7.22004107 |
| 9 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.85332276 |
| 10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.72979356 |
| 11 | atrial septum morphogenesis (GO:0060413) | 6.68460211 |
| 12 | plasma membrane repair (GO:0001778) | 6.67963760 |
| 13 | * actin-myosin filament sliding (GO:0033275) | 6.51514327 |
| 14 | * muscle filament sliding (GO:0030049) | 6.51514327 |
| 15 | regulation of actin filament-based movement (GO:1903115) | 6.45349521 |
| 16 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.27887417 |
| 17 | * cardiac muscle cell development (GO:0055013) | 6.27796771 |
| 18 | ventricular cardiac muscle cell action potential (GO:0086005) | 6.23760146 |
| 19 | * ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 6.13953258 |
| 20 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.09229678 |
| 21 | * cardiac muscle tissue morphogenesis (GO:0055008) | 6.05849653 |
| 22 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 6.05809126 |
| 23 | * actomyosin structure organization (GO:0031032) | 5.97497488 |
| 24 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.91464365 |
| 25 | * cardiac cell development (GO:0055006) | 5.89599602 |
| 26 | tricarboxylic acid cycle (GO:0006099) | 5.85859807 |
| 27 | regulation of relaxation of muscle (GO:1901077) | 5.75854038 |
| 28 | cardiac muscle hypertrophy (GO:0003300) | 5.68853032 |
| 29 | atrioventricular valve morphogenesis (GO:0003181) | 5.64077587 |
| 30 | * adult heart development (GO:0007512) | 5.55616380 |
| 31 | regulation of skeletal muscle contraction (GO:0014819) | 5.43669653 |
| 32 | striated muscle hypertrophy (GO:0014897) | 5.36634447 |
| 33 | heart trabecula formation (GO:0060347) | 5.36532072 |
| 34 | * muscle tissue morphogenesis (GO:0060415) | 5.35258757 |
| 35 | * actin-mediated cell contraction (GO:0070252) | 5.34589971 |
| 36 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.23683776 |
| 37 | regulation of striated muscle contraction (GO:0006942) | 5.20277395 |
| 38 | heart contraction (GO:0060047) | 5.19396623 |
| 39 | heart process (GO:0003015) | 5.19396623 |
| 40 | * striated muscle contraction (GO:0006941) | 5.11661681 |
| 41 | regulation of sarcomere organization (GO:0060297) | 5.03657112 |
| 42 | cell communication involved in cardiac conduction (GO:0086065) | 5.03127883 |
| 43 | carnitine shuttle (GO:0006853) | 4.93137705 |
| 44 | cardiac muscle tissue development (GO:0048738) | 4.89313359 |
| 45 | negative regulation of myotube differentiation (GO:0010832) | 4.88864082 |
| 46 | oxygen transport (GO:0015671) | 4.83308403 |
| 47 | regulation of membrane repolarization (GO:0060306) | 4.77218948 |
| 48 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.75497144 |
| 49 | muscle hypertrophy (GO:0014896) | 4.75323962 |
| 50 | regulation of cardioblast proliferation (GO:0003264) | 4.68710978 |
| 51 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 4.68710978 |
| 52 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 4.68122361 |
| 53 | outflow tract septum morphogenesis (GO:0003148) | 4.67115312 |
| 54 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 4.55330097 |
| 55 | * regulation of the force of heart contraction (GO:0002026) | 4.53915395 |
| 56 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.52028043 |
| 57 | cell communication by electrical coupling (GO:0010644) | 4.50689308 |
| 58 | positive regulation of cardiac muscle cell proliferation (GO:0060045) | 4.46725060 |
| 59 | regulation of cell communication by electrical coupling (GO:0010649) | 4.44521138 |
| 60 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 4.40984272 |
| 61 | regulation of cardiac muscle contraction (GO:0055117) | 4.40350737 |
| 62 | cell migration involved in heart development (GO:0060973) | 4.39255631 |
| 63 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.37948859 |
| 64 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.36102490 |
| 65 | negative regulation of protein localization to cell surface (GO:2000009) | 4.34326971 |
| 66 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.30529921 |
| 67 | positive regulation of cardiac muscle tissue growth (GO:0055023) | 4.30055694 |
| 68 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.28665113 |
| 69 | regulation of cardioblast differentiation (GO:0051890) | 4.28048776 |
| 70 | cardiac muscle cell action potential (GO:0086001) | 4.22439174 |
| 71 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.17240855 |
| 72 | fatty acid transmembrane transport (GO:1902001) | 4.15600658 |
| 73 | positive regulation of cardiac muscle tissue development (GO:0055025) | 4.13516951 |
| 74 | positive regulation of ATP catabolic process (GO:1903291) | 4.12778368 |
| 75 | positive regulation of ATPase activity (GO:0032781) | 4.12778368 |
| 76 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.11553340 |
| 77 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.11233477 |
| 78 | * regulation of heart rate (GO:0002027) | 4.08418044 |
| 79 | negative regulation of potassium ion transport (GO:0043267) | 4.06756017 |
| 80 | * actin filament-based movement (GO:0030048) | 4.04536045 |
| 81 | endocardial cushion development (GO:0003197) | 4.04070962 |
| 82 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.94751370 |
| 83 | muscle hypertrophy in response to stress (GO:0003299) | 3.94751370 |
| 84 | cardiac muscle adaptation (GO:0014887) | 3.94751370 |
| 85 | * regulation of heart contraction (GO:0008016) | 3.93189956 |
| 86 | positive regulation of heart rate (GO:0010460) | 3.92349483 |
| 87 | regulation of cardiac muscle cell proliferation (GO:0060043) | 3.90623902 |
| 88 | cardiac right ventricle morphogenesis (GO:0003215) | 3.90540883 |
| 89 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.87122604 |
| 90 | ATP synthesis coupled proton transport (GO:0015986) | 3.87122604 |
| 91 | NADH metabolic process (GO:0006734) | 3.85225834 |
| 92 | positive regulation of heart contraction (GO:0045823) | 3.85043252 |
| 93 | positive regulation of heart growth (GO:0060421) | 3.83820362 |
| 94 | relaxation of cardiac muscle (GO:0055119) | 3.79568248 |
| 95 | striated muscle adaptation (GO:0014888) | 3.79322281 |
| 96 | 2-oxoglutarate metabolic process (GO:0006103) | 3.75188682 |
| 97 | regulation of cofactor metabolic process (GO:0051193) | 3.73670863 |
| 98 | regulation of coenzyme metabolic process (GO:0051196) | 3.73670863 |
| 99 | * regulation of ATPase activity (GO:0043462) | 3.72310847 |
| 100 | * regulation of ATP catabolic process (GO:1903289) | 3.72310847 |
| 101 | positive regulation of cation channel activity (GO:2001259) | 3.69420713 |
| 102 | regulation of cardiac muscle tissue development (GO:0055024) | 3.66396248 |
| 103 | ventricular cardiac muscle cell development (GO:0055015) | 3.65492240 |
| 104 | adrenergic receptor signaling pathway (GO:0071875) | 3.64568597 |
| 105 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.64209821 |
| 106 | carnitine transmembrane transport (GO:1902603) | 3.63351631 |
| 107 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.63285073 |
| 108 | cardiac septum development (GO:0003279) | 3.62465291 |
| 109 | embryonic heart tube development (GO:0035050) | 3.60096445 |
| 110 | cardiac conduction (GO:0061337) | 3.57763543 |
| 111 | creatine metabolic process (GO:0006600) | 3.56903977 |
| 112 | desmosome organization (GO:0002934) | 3.52979133 |
| 113 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.50595590 |
| 114 | trabecula formation (GO:0060343) | 3.49247602 |
| 115 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.48847870 |
| 116 | regulation of sequestering of triglyceride (GO:0010889) | 3.48453406 |
| 117 | cellular response to epinephrine stimulus (GO:0071872) | 3.47966856 |
| 118 | regulation of muscle contraction (GO:0006937) | 3.46861289 |
| 119 | relaxation of muscle (GO:0090075) | 3.46471083 |
| 120 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.46087528 |
| 121 | regulation of cardiac muscle tissue growth (GO:0055021) | 3.43508528 |
| 122 | respiratory electron transport chain (GO:0022904) | 3.43252427 |
| 123 | response to inactivity (GO:0014854) | 3.42679516 |
| 124 | cardiac muscle cell proliferation (GO:0060038) | 3.42481062 |
| 125 | potassium ion export (GO:0071435) | 3.36808973 |
| 126 | pericardium development (GO:0060039) | 3.36662077 |
| 127 | * striated muscle cell development (GO:0055002) | 3.36416264 |
| 128 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.36086288 |
| 129 | gap junction assembly (GO:0016264) | 3.35347428 |
| 130 | electron transport chain (GO:0022900) | 3.32500475 |
| 131 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.32285583 |
| 132 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.32285583 |
| 133 | response to epinephrine (GO:0071871) | 3.31925244 |
| 134 | amino-acid betaine transport (GO:0015838) | 3.30541131 |
| 135 | carnitine transport (GO:0015879) | 3.30541131 |
| 136 | detection of calcium ion (GO:0005513) | 3.20521115 |
| 137 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.18323711 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.99107974 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.83844592 |
| 3 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.13407195 |
| 4 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.13407195 |
| 5 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.87586297 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.50343379 |
| 7 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.38856702 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.22818957 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.97728400 |
| 10 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.97544246 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.66033898 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.59687418 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.40736532 |
| 14 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.35563963 |
| 15 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.33185945 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.29375798 |
| 17 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.22876623 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.09580987 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.05221179 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.04436342 |
| 21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.96456006 |
| 22 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.93305077 |
| 23 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.79457009 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.79143213 |
| 25 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.73741154 |
| 26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.69348005 |
| 27 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.64302640 |
| 28 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.64302640 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.60208496 |
| 30 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.59866006 |
| 31 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.59016144 |
| 32 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.58366753 |
| 33 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.54916056 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53663541 |
| 35 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.50717117 |
| 36 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.50693548 |
| 37 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.50473055 |
| 38 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.49208061 |
| 39 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.47681481 |
| 40 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.47034028 |
| 41 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.46340648 |
| 42 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.46290736 |
| 43 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.46255847 |
| 44 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.43757670 |
| 45 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.39799328 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39522657 |
| 47 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.39373664 |
| 48 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37057041 |
| 49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33871698 |
| 50 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.33238428 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.33224324 |
| 52 | GATA1_19941826_ChIP-Seq_K562_Human | 1.32960016 |
| 53 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.32355605 |
| 54 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.32036812 |
| 55 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.31898452 |
| 56 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.30999683 |
| 57 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.30827104 |
| 58 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.30000277 |
| 59 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.29837523 |
| 60 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.26950989 |
| 61 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.26758167 |
| 62 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.25685745 |
| 63 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.25464124 |
| 64 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.23823259 |
| 65 | VDR_22108803_ChIP-Seq_LS180_Human | 1.22713565 |
| 66 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.21510720 |
| 67 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.19644793 |
| 68 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.18713617 |
| 69 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.18390864 |
| 70 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.17920607 |
| 71 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.16477407 |
| 72 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.14936204 |
| 73 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13273366 |
| 74 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.12920836 |
| 75 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12105828 |
| 76 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.11147250 |
| 77 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.09635431 |
| 78 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.09300118 |
| 79 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.08828178 |
| 80 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.07800565 |
| 81 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.07650513 |
| 82 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.07326471 |
| 83 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.07040389 |
| 84 | P68_20966046_ChIP-Seq_HELA_Human | 1.06581794 |
| 85 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.05632139 |
| 86 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05143213 |
| 87 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.04875262 |
| 88 | KDM2B_26808549_Chip-Seq_K562_Human | 1.03721051 |
| 89 | ATF3_27146783_Chip-Seq_COLON_Human | 1.02876180 |
| 90 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.02840333 |
| 91 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.02818676 |
| 92 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.02521522 |
| 93 | SPI1_23127762_ChIP-Seq_K562_Human | 1.01938782 |
| 94 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01258877 |
| 95 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.00861281 |
| 96 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.99762022 |
| 97 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.99533283 |
| 98 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.99017782 |
| 99 | TP53_16413492_ChIP-PET_HCT116_Human | 0.98811884 |
| 100 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98790541 |
| 101 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.98679747 |
| 102 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98406723 |
| 103 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.98000010 |
| 104 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.97985926 |
| 105 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.96786524 |
| 106 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96463042 |
| 107 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.96343502 |
| 108 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96184906 |
| 109 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95837591 |
| 110 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.95673183 |
| 111 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.95630574 |
| 112 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.93785623 |
| 113 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.92572769 |
| 114 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92239784 |
| 115 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92113715 |
| 116 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92028485 |
| 117 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.91770390 |
| 118 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.91109044 |
| 119 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.91071187 |
| 120 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90356892 |
| 121 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.89444592 |
| 122 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.89272409 |
| 123 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.88312970 |
| 124 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.88049286 |
| 125 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.86695463 |
| 126 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86528955 |
| 127 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85362934 |
| 128 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.85350162 |
| 129 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.85054663 |
| 130 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.85038825 |
| 131 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84984492 |
| 132 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84984492 |
| 133 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84902529 |
| 134 | TBL1_22424771_ChIP-Seq_293T_Human | 0.84773374 |
| 135 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84698581 |
| 136 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.84458479 |
| 137 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.84409301 |
| 138 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.84327322 |
| 139 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.83811739 |
| 140 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.83576689 |
| 141 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.83337731 |
| 142 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.83271308 |
| 143 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.83128885 |
| 144 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.83005351 |
| 145 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.81934556 |
| 146 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.81634784 |
| 147 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.81318009 |
| 148 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.80292439 |
| 149 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.80134074 |
| 150 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.79676815 |
| 151 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.79431862 |
| 152 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.79225519 |
| 153 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.78844247 |
| 154 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.78753437 |
| 155 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.77896697 |
| 156 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.77689992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0002837_dystrophic_cardiac_calcinosis | 6.37935883 |
| 2 | MP0003646_muscle_fatigue | 5.98247198 |
| 3 | * MP0004084_abnormal_cardiac_muscle | 5.68026920 |
| 4 | MP0000751_myopathy | 5.40924270 |
| 5 | * MP0004215_abnormal_myocardial_fiber | 4.88342792 |
| 6 | * MP0004036_abnormal_muscle_relaxation | 4.02657994 |
| 7 | * MP0005330_cardiomyopathy | 3.85273054 |
| 8 | MP0000749_muscle_degeneration | 3.77000549 |
| 9 | * MP0002972_abnormal_cardiac_muscle | 3.29536302 |
| 10 | MP0003137_abnormal_impulse_conducting | 3.25020009 |
| 11 | MP0008775_abnormal_heart_ventricle | 3.17310759 |
| 12 | * MP0004087_abnormal_muscle_fiber | 3.04755405 |
| 13 | MP0006138_congestive_heart_failure | 2.84795021 |
| 14 | MP0000750_abnormal_muscle_regeneration | 2.80505062 |
| 15 | * MP0005385_cardiovascular_system_phenoty | 2.76022632 |
| 16 | * MP0001544_abnormal_cardiovascular_syste | 2.76022632 |
| 17 | * MP0010630_abnormal_cardiac_muscle | 2.70244843 |
| 18 | * MP0005620_abnormal_muscle_contractility | 2.62121452 |
| 19 | MP0003828_pulmonary_edema | 2.58854809 |
| 20 | MP0002106_abnormal_muscle_physiology | 2.41283201 |
| 21 | MP0004484_altered_response_of | 2.38333368 |
| 22 | MP0002269_muscular_atrophy | 2.26610706 |
| 23 | MP0004130_abnormal_muscle_cell | 2.23651002 |
| 24 | * MP0004085_abnormal_heartbeat | 2.22480158 |
| 25 | MP0004510_myositis | 2.18167484 |
| 26 | MP0005369_muscle_phenotype | 1.95116456 |
| 27 | MP0003221_abnormal_cardiomyocyte_apopto | 1.93821818 |
| 28 | MP0000759_abnormal_skeletal_muscle | 1.85303418 |
| 29 | MP0002127_abnormal_cardiovascular_syste | 1.80253303 |
| 30 | MP0000747_muscle_weakness | 1.72250626 |
| 31 | MP0003950_abnormal_plasma_membrane | 1.69765713 |
| 32 | MP0004233_abnormal_muscle_weight | 1.62611120 |
| 33 | MP0004145_abnormal_muscle_electrophysio | 1.58214336 |
| 34 | MP0005670_abnormal_white_adipose | 1.52044707 |
| 35 | MP0005666_abnormal_adipose_tissue | 1.46846188 |
| 36 | MP0006036_abnormal_mitochondrial_physio | 1.44169162 |
| 37 | MP0010368_abnormal_lymphatic_system | 1.43204865 |
| 38 | MP0003279_aneurysm | 1.37508297 |
| 39 | MP0003567_abnormal_fetal_cardiomyocyte | 1.33186931 |
| 40 | MP0003941_abnormal_skin_development | 1.31667146 |
| 41 | MP0002332_abnormal_exercise_endurance | 1.29457804 |
| 42 | MP0000343_altered_response_to | 1.22029933 |
| 43 | * MP0000266_abnormal_heart_morphology | 1.19383492 |
| 44 | MP0002234_abnormal_pharynx_morphology | 1.15005535 |
| 45 | MP0005165_increased_susceptibility_to | 1.12343501 |
| 46 | MP0000537_abnormal_urethra_morphology | 1.05856179 |
| 47 | MP0005623_abnormal_meninges_morphology | 1.02579498 |
| 48 | MP0005503_abnormal_tendon_morphology | 1.02551600 |
| 49 | MP0001661_extended_life_span | 1.02247908 |
| 50 | MP0002102_abnormal_ear_morphology | 0.99587954 |
| 51 | MP0005375_adipose_tissue_phenotype | 0.98968326 |
| 52 | MP0003705_abnormal_hypodermis_morpholog | 0.97074481 |
| 53 | MP0004185_abnormal_adipocyte_glucose | 0.93917432 |
| 54 | MP0003566_abnormal_cell_adhesion | 0.91346193 |
| 55 | * MP0002128_abnormal_blood_circulation | 0.87943268 |
| 56 | MP0000230_abnormal_systemic_arterial | 0.84608794 |
| 57 | MP0006035_abnormal_mitochondrial_morpho | 0.84130976 |
| 58 | MP0000462_abnormal_digestive_system | 0.80959534 |
| 59 | MP0005266_abnormal_metabolism | 0.80518731 |
| 60 | MP0000767_abnormal_smooth_muscle | 0.80466151 |
| 61 | MP0008004_abnormal_stomach_pH | 0.76909456 |
| 62 | MP0001879_abnormal_lymphatic_vessel | 0.75124075 |
| 63 | MP0002108_abnormal_muscle_morphology | 0.74889362 |
| 64 | MP0002909_abnormal_adrenal_gland | 0.74576598 |
| 65 | MP0005451_abnormal_body_composition | 0.70936157 |
| 66 | MP0008438_abnormal_cutaneous_collagen | 0.69450258 |
| 67 | MP0004272_abnormal_basement_membrane | 0.67723589 |
| 68 | MP0003937_abnormal_limbs/digits/tail_de | 0.65751373 |
| 69 | MP0005187_abnormal_penis_morphology | 0.64982681 |
| 70 | MP0003806_abnormal_nucleotide_metabolis | 0.64202161 |
| 71 | MP0002925_abnormal_cardiovascular_devel | 0.56477506 |
| 72 | MP0005367_renal/urinary_system_phenotyp | 0.54584882 |
| 73 | MP0000516_abnormal_urinary_system | 0.54584882 |
| 74 | MP0000003_abnormal_adipose_tissue | 0.53480541 |
| 75 | MP0005248_abnormal_Harderian_gland | 0.53354222 |
| 76 | MP0003385_abnormal_body_wall | 0.50458412 |
| 77 | MP0005319_abnormal_enzyme/_coenzyme | 0.48501905 |
| 78 | MP0003984_embryonic_growth_retardation | 0.47827963 |
| 79 | MP0009250_abnormal_appendicular_skeleto | 0.47615077 |
| 80 | MP0002088_abnormal_embryonic_growth/wei | 0.46192816 |
| 81 | MP0005275_abnormal_skin_tensile | 0.43985622 |
| 82 | MP0001299_abnormal_eye_distance/ | 0.43284868 |
| 83 | MP0001614_abnormal_blood_vessel | 0.42701043 |
| 84 | MP0000733_abnormal_muscle_development | 0.42673102 |
| 85 | MP0001784_abnormal_fluid_regulation | 0.42236952 |
| 86 | MP0002078_abnormal_glucose_homeostasis | 0.41686575 |
| 87 | MP0000579_abnormal_nail_morphology | 0.41252200 |
| 88 | MP0008961_abnormal_basal_metabolism | 0.40983604 |
| 89 | MP0003935_abnormal_craniofacial_develop | 0.40979217 |
| 90 | MP0000013_abnormal_adipose_tissue | 0.40764838 |
| 91 | MP0002249_abnormal_larynx_morphology | 0.40483937 |
| 92 | MP0001958_emphysema | 0.40086011 |
| 93 | MP0004043_abnormal_pH_regulation | 0.39600777 |
| 94 | MP0001730_embryonic_growth_arrest | 0.39233960 |
| 95 | MP0000762_abnormal_tongue_morphology | 0.38850221 |
| 96 | MP0009840_abnormal_foam_cell | 0.38235015 |
| 97 | MP0000534_abnormal_ureter_morphology | 0.36523591 |
| 98 | MP0002971_abnormal_brown_adipose | 0.35467769 |
| 99 | MP0005595_abnormal_vascular_smooth | 0.35252625 |
| 100 | MP0003948_abnormal_gas_homeostasis | 0.34573013 |
| 101 | MP0009384_cardiac_valve_regurgitation | 0.33872942 |
| 102 | MP0005167_abnormal_blood-brain_barrier | 0.33849132 |
| 103 | MP0002295_abnormal_pulmonary_circulatio | 0.33779258 |
| 104 | MP0002822_catalepsy | 0.33500666 |
| 105 | MP0004147_increased_porphyrin_level | 0.32074059 |
| 106 | MP0004924_abnormal_behavior | 0.30075131 |
| 107 | MP0005386_behavior/neurological_phenoty | 0.30075131 |
| 108 | MP0005083_abnormal_biliary_tract | 0.28675619 |
| 109 | MP0005535_abnormal_body_temperature | 0.28290250 |
| 110 | MP0003942_abnormal_urinary_system | 0.27332215 |
| 111 | MP0002133_abnormal_respiratory_system | 0.26513231 |
| 112 | MP0005388_respiratory_system_phenotype | 0.26513231 |
| 113 | MP0000249_abnormal_blood_vessel | 0.26481722 |
| 114 | MP0009780_abnormal_chondrocyte_physiolo | 0.26463143 |
| 115 | MP0001672_abnormal_embryogenesis/_devel | 0.25669029 |
| 116 | MP0005380_embryogenesis_phenotype | 0.25669029 |
| 117 | MP0003119_abnormal_digestive_system | 0.25064132 |
| 118 | MP0005334_abnormal_fat_pad | 0.24811237 |
| 119 | MP0002118_abnormal_lipid_homeostasis | 0.23773337 |
| 120 | MP0003045_fibrosis | 0.23657044 |
| 121 | MP0001727_abnormal_embryo_implantation | 0.23610279 |
| 122 | MP0001697_abnormal_embryo_size | 0.23470897 |
| 123 | MP0002086_abnormal_extraembryonic_tissu | 0.23324807 |
| 124 | MP0009115_abnormal_fat_cell | 0.23152453 |
| 125 | MP0006072_abnormal_retinal_apoptosis | 0.22690130 |
| 126 | MP0005409_darkened_coat_color | 0.22566073 |
| 127 | MP0002970_abnormal_white_adipose | 0.18882543 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 9.27414733 |
| 2 | Ventricular tachycardia (HP:0004756) | 7.76237615 |
| 3 | Atrial fibrillation (HP:0005110) | 6.66329007 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 6.43520975 |
| 5 | Primary atrial arrhythmia (HP:0001692) | 6.24000108 |
| 6 | Muscle fiber splitting (HP:0003555) | 6.14850634 |
| 7 | Supraventricular tachycardia (HP:0004755) | 6.03990342 |
| 8 | Supraventricular arrhythmia (HP:0005115) | 5.93498353 |
| 9 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.72624373 |
| 10 | * Lipoatrophy (HP:0100578) | 5.71603709 |
| 11 | Subaortic stenosis (HP:0001682) | 5.69114974 |
| 12 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.69114974 |
| 13 | Abnormality of the calf musculature (HP:0001430) | 5.50657379 |
| 14 | Right ventricular cardiomyopathy (HP:0011663) | 5.47239349 |
| 15 | Exercise-induced muscle cramps (HP:0003710) | 5.25734074 |
| 16 | Syncope (HP:0001279) | 5.19627299 |
| 17 | Hyporeflexia of lower limbs (HP:0002600) | 5.13186112 |
| 18 | Exercise-induced myalgia (HP:0003738) | 5.06246741 |
| 19 | Bundle branch block (HP:0011710) | 4.95933591 |
| 20 | Prolonged QT interval (HP:0001657) | 4.84140160 |
| 21 | Palpitations (HP:0001962) | 4.70902667 |
| 22 | * Dilated cardiomyopathy (HP:0001644) | 4.63443163 |
| 23 | Asymmetric septal hypertrophy (HP:0001670) | 4.38729966 |
| 24 | EMG: myopathic abnormalities (HP:0003458) | 4.35133819 |
| 25 | Ventricular arrhythmia (HP:0004308) | 4.33686302 |
| 26 | Ventricular fibrillation (HP:0001663) | 4.23072359 |
| 27 | Atrioventricular block (HP:0001678) | 4.16309264 |
| 28 | Heart block (HP:0012722) | 4.14156347 |
| 29 | Increased connective tissue (HP:0009025) | 4.10192213 |
| 30 | Myoglobinuria (HP:0002913) | 4.05960837 |
| 31 | Hypoplastic heart (HP:0001961) | 3.96727281 |
| 32 | Abnormal atrioventricular conduction (HP:0005150) | 3.91421656 |
| 33 | Bradycardia (HP:0001662) | 3.72776758 |
| 34 | Myotonia (HP:0002486) | 3.45750926 |
| 35 | Abnormal EKG (HP:0003115) | 3.45279586 |
| 36 | Difficulty running (HP:0009046) | 3.26967323 |
| 37 | Left ventricular hypertrophy (HP:0001712) | 3.08001733 |
| 38 | Rhabdomyolysis (HP:0003201) | 3.01501520 |
| 39 | Difficulty climbing stairs (HP:0003551) | 2.99453333 |
| 40 | Hip contracture (HP:0003273) | 2.88696961 |
| 41 | Abnormal ventriculo-arterial connection (HP:0011563) | 2.88490332 |
| 42 | Transposition of the great arteries (HP:0001669) | 2.88490332 |
| 43 | Abnormal connection of the cardiac segments (HP:0011545) | 2.88490332 |
| 44 | Preauricular pit (HP:0004467) | 2.81651316 |
| 45 | Periauricular skin pits (HP:0100277) | 2.81651316 |
| 46 | * Palmoplantar keratoderma (HP:0000982) | 2.79659681 |
| 47 | Testicular atrophy (HP:0000029) | 2.79548121 |
| 48 | Patent foramen ovale (HP:0001655) | 2.78801318 |
| 49 | Partial duplication of thumb phalanx (HP:0009944) | 2.64123276 |
| 50 | Hepatic necrosis (HP:0002605) | 2.60873118 |
| 51 | Ketoacidosis (HP:0001993) | 2.60842172 |
| 52 | Skin pits (HP:0100276) | 2.60413616 |
| 53 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.55930804 |
| 54 | Ragged-red muscle fibers (HP:0003200) | 2.55113280 |
| 55 | Acute necrotizing encephalopathy (HP:0006965) | 2.53972060 |
| 56 | Limb-girdle muscle atrophy (HP:0003797) | 2.52498291 |
| 57 | Aplasia of the musculature (HP:0100854) | 2.50185735 |
| 58 | Distal lower limb muscle weakness (HP:0009053) | 2.43802932 |
| 59 | Abnormality of the foot musculature (HP:0001436) | 2.40587247 |
| 60 | Increased variability in muscle fiber diameter (HP:0003557) | 2.37189156 |
| 61 | Hepatocellular necrosis (HP:0001404) | 2.32069509 |
| 62 | Partial duplication of the phalanx of hand (HP:0009999) | 2.31170918 |
| 63 | Sudden cardiac death (HP:0001645) | 2.28477165 |
| 64 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.27922500 |
| 65 | Neck muscle weakness (HP:0000467) | 2.27648153 |
| 66 | Anomalous pulmonary venous return (HP:0010772) | 2.25620042 |
| 67 | Hypoglycemic coma (HP:0001325) | 2.24973315 |
| 68 | Dysmetric saccades (HP:0000641) | 2.24336332 |
| 69 | Rimmed vacuoles (HP:0003805) | 2.21533440 |
| 70 | Truncus arteriosus (HP:0001660) | 2.20293974 |
| 71 | Acute encephalopathy (HP:0006846) | 2.19179037 |
| 72 | Areflexia of lower limbs (HP:0002522) | 2.18987200 |
| 73 | Congestive heart failure (HP:0001635) | 2.16993186 |
| 74 | Distal lower limb amyotrophy (HP:0008944) | 2.16833865 |
| 75 | Foot dorsiflexor weakness (HP:0009027) | 2.15672734 |
| 76 | Increased muscle lipid content (HP:0009058) | 2.14005577 |
| 77 | Conjunctival hamartoma (HP:0100780) | 2.13689690 |
| 78 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.12212225 |
| 79 | Limited hip movement (HP:0008800) | 2.12155658 |
| 80 | Mitochondrial inheritance (HP:0001427) | 2.11748728 |
| 81 | Large for gestational age (HP:0001520) | 2.08153172 |
| 82 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.06650268 |
| 83 | Cerebral edema (HP:0002181) | 2.06335657 |
| 84 | Progressive macrocephaly (HP:0004481) | 2.05540105 |
| 85 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.04338059 |
| 86 | Dicarboxylic aciduria (HP:0003215) | 2.04338059 |
| 87 | Vitreoretinal degeneration (HP:0000655) | 2.02135430 |
| 88 | EMG: neuropathic changes (HP:0003445) | 1.97184152 |
| 89 | Pulmonary artery stenosis (HP:0004415) | 1.96044983 |
| 90 | Pheochromocytoma (HP:0002666) | 1.96006779 |
| 91 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.94616771 |
| 92 | Double outlet right ventricle (HP:0001719) | 1.93973720 |
| 93 | Congenital malformation of the right heart (HP:0011723) | 1.93973720 |
| 94 | Increased CSF lactate (HP:0002490) | 1.93625778 |
| 95 | Ketosis (HP:0001946) | 1.93587113 |
| 96 | Type 1 muscle fiber predominance (HP:0003803) | 1.93007936 |
| 97 | Muscle stiffness (HP:0003552) | 1.92644140 |
| 98 | Abnormality of the pulmonary veins (HP:0011718) | 1.92602341 |
| 99 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.91811263 |
| 100 | Muscular dystrophy (HP:0003560) | 1.91025521 |
| 101 | Steppage gait (HP:0003376) | 1.88975816 |
| 102 | Broad metatarsal (HP:0001783) | 1.88270860 |
| 103 | Hamartoma of the eye (HP:0010568) | 1.88121883 |
| 104 | Hypoplastic ischia (HP:0003175) | 1.85571994 |
| 105 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.85357677 |
| 106 | Abnormality of the tricuspid valve (HP:0001702) | 1.84759416 |
| 107 | Respiratory failure (HP:0002878) | 1.84314452 |
| 108 | Abnormality of the ischium (HP:0003174) | 1.83370047 |
| 109 | Diaphragmatic weakness (HP:0009113) | 1.82407788 |
| 110 | Maternal diabetes (HP:0009800) | 1.81921102 |
| 111 | Exercise intolerance (HP:0003546) | 1.81149508 |
| 112 | Increased intramyocellular lipid droplets (HP:0012240) | 1.80888481 |
| 113 | Lymphangioma (HP:0100764) | 1.80477074 |
| 114 | Scapular winging (HP:0003691) | 1.79851761 |
| 115 | Metaphyseal cupping (HP:0003021) | 1.79397902 |
| 116 | Resting tremor (HP:0002322) | 1.79029130 |
| 117 | Neoplasm of head and neck (HP:0012288) | 1.77725569 |
| 118 | Esophageal neoplasm (HP:0100751) | 1.77725569 |
| 119 | Muscle fiber inclusion bodies (HP:0100299) | 1.76166422 |
| 120 | Lactic acidosis (HP:0003128) | 1.74626704 |
| 121 | Gowers sign (HP:0003391) | 1.74445160 |
| 122 | Complete atrioventricular canal defect (HP:0001674) | 1.74221812 |
| 123 | Generalized muscle weakness (HP:0003324) | 1.73515568 |
| 124 | Neoplasm of the adrenal gland (HP:0100631) | 1.72841733 |
| 125 | Hypoplastic left heart (HP:0004383) | 1.71220053 |
| 126 | Neuroendocrine neoplasm (HP:0100634) | 1.71043339 |
| 127 | Lower limb amyotrophy (HP:0007210) | 1.70019547 |
| 128 | Toxemia of pregnancy (HP:0100603) | 1.65209820 |
| 129 | Coarctation of aorta (HP:0001680) | 1.56106637 |
| 130 | Aneurysm (HP:0002617) | 1.53599663 |
| 131 | Bicuspid aortic valve (HP:0001647) | 1.53575673 |
| 132 | Skin nodule (HP:0200036) | 1.51421942 |
| 133 | Prenatal maternal abnormality (HP:0002686) | 1.50688480 |
| 134 | Limb hypertonia (HP:0002509) | 1.47675699 |
| 135 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.47591213 |
| 136 | Abnormality of the endocardium (HP:0004306) | 1.46723537 |
| 137 | Late onset (HP:0003584) | 1.46334106 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.79668380 |
| 2 | LMTK2 | 4.63352059 |
| 3 | MYLK | 4.44483649 |
| 4 | PHKG2 | 3.90870779 |
| 5 | PHKG1 | 3.90870779 |
| 6 | OBSCN | 3.69101473 |
| 7 | DMPK | 3.36308292 |
| 8 | PKN2 | 2.97803797 |
| 9 | PDK3 | 2.88497360 |
| 10 | PDK4 | 2.88497360 |
| 11 | TRIB3 | 2.79395240 |
| 12 | MUSK | 2.66145986 |
| 13 | PIK3CA | 2.59118379 |
| 14 | BCKDK | 2.32854760 |
| 15 | TIE1 | 2.29640677 |
| 16 | NEK1 | 1.93305629 |
| 17 | NEK9 | 1.86510528 |
| 18 | PAK3 | 1.74061623 |
| 19 | DDR2 | 1.68243084 |
| 20 | PDK2 | 1.66541325 |
| 21 | PINK1 | 1.64352871 |
| 22 | PRKD1 | 1.57767915 |
| 23 | STK24 | 1.51965407 |
| 24 | CAMK2D | 1.46696744 |
| 25 | CDC42BPA | 1.45462509 |
| 26 | STK4 | 1.27261800 |
| 27 | ROCK1 | 1.24963847 |
| 28 | LATS1 | 1.23523549 |
| 29 | ILK | 1.22969617 |
| 30 | RIPK1 | 1.18327008 |
| 31 | DAPK3 | 1.14601174 |
| 32 | GRK7 | 1.10895631 |
| 33 | MAP3K5 | 1.10035691 |
| 34 | WNK4 | 1.06323381 |
| 35 | MARK1 | 1.05169360 |
| 36 | MAPKAPK3 | 1.03485542 |
| 37 | PKN1 | 1.01283981 |
| 38 | UHMK1 | 0.93566373 |
| 39 | MAPK12 | 0.93312099 |
| 40 | PDGFRA | 0.92976991 |
| 41 | LIMK1 | 0.88404939 |
| 42 | PRKAA1 | 0.83867578 |
| 43 | EPHB1 | 0.83696998 |
| 44 | INSRR | 0.83220525 |
| 45 | ROCK2 | 0.83015817 |
| 46 | MAP3K7 | 0.80867659 |
| 47 | RPS6KC1 | 0.80212112 |
| 48 | RPS6KL1 | 0.80212112 |
| 49 | PRKAA2 | 0.77525520 |
| 50 | ZAK | 0.75423319 |
| 51 | KDR | 0.75275256 |
| 52 | STK38 | 0.74582646 |
| 53 | TRPM7 | 0.71827719 |
| 54 | PTK2B | 0.70946141 |
| 55 | MAP3K6 | 0.70752609 |
| 56 | CAMK4 | 0.70394708 |
| 57 | FLT3 | 0.70237057 |
| 58 | RPS6KA6 | 0.70061917 |
| 59 | STK38L | 0.69063904 |
| 60 | ICK | 0.68644039 |
| 61 | TGFBR2 | 0.68137596 |
| 62 | MAPK4 | 0.64023969 |
| 63 | CAMK2A | 0.63164041 |
| 64 | SIK1 | 0.61780512 |
| 65 | PRKCE | 0.60954660 |
| 66 | WNK1 | 0.59859936 |
| 67 | PRKACB | 0.56433125 |
| 68 | MAP3K3 | 0.56171323 |
| 69 | MAP2K3 | 0.53538774 |
| 70 | FGFR1 | 0.50861304 |
| 71 | CAMK1 | 0.49708309 |
| 72 | AKT3 | 0.48801273 |
| 73 | ITK | 0.47040751 |
| 74 | PRKACG | 0.44358815 |
| 75 | CAMK2B | 0.43366733 |
| 76 | PRKCH | 0.43255245 |
| 77 | PRKACA | 0.41304799 |
| 78 | PTK6 | 0.40797359 |
| 79 | DYRK1B | 0.40260844 |
| 80 | NLK | 0.39995701 |
| 81 | PDPK1 | 0.38050576 |
| 82 | EPHB2 | 0.37900799 |
| 83 | PRKD3 | 0.37746303 |
| 84 | MTOR | 0.34462996 |
| 85 | PRKG2 | 0.32843072 |
| 86 | KSR2 | 0.32243186 |
| 87 | MAP2K1 | 0.31912859 |
| 88 | RPS6KB2 | 0.31529788 |
| 89 | PTK2 | 0.30910470 |
| 90 | PAK2 | 0.29488008 |
| 91 | FER | 0.29198889 |
| 92 | RPS6KA1 | 0.28433999 |
| 93 | AKT2 | 0.27376246 |
| 94 | RAF1 | 0.27354606 |
| 95 | RPS6KA2 | 0.26967136 |
| 96 | PDK1 | 0.25621941 |
| 97 | CDK4 | 0.25309125 |
| 98 | STK39 | 0.24899349 |
| 99 | LATS2 | 0.24065676 |
| 100 | MAPK10 | 0.23979217 |
| 101 | FGFR4 | 0.23632309 |
| 102 | JAK1 | 0.23349009 |
| 103 | MAP3K10 | 0.23346209 |
| 104 | PIK3CG | 0.23268196 |
| 105 | SGK3 | 0.22566060 |
| 106 | KSR1 | 0.22558958 |
| 107 | CAMK2G | 0.21234258 |
| 108 | CDK5 | 0.20257143 |
| 109 | TGFBR1 | 0.19537976 |
| 110 | TAOK1 | 0.19473292 |
| 111 | RET | 0.19150663 |
| 112 | MARK2 | 0.19052424 |
| 113 | PRKG1 | 0.18831191 |
| 114 | EEF2K | 0.18618882 |
| 115 | CAMK1D | 0.17885166 |
| 116 | PDGFRB | 0.17610265 |
| 117 | EPHA3 | 0.17394101 |
| 118 | CAMK1G | 0.17306466 |
| 119 | FGFR3 | 0.16782770 |
| 120 | EPHA4 | 0.16594815 |
| 121 | RPS6KA3 | 0.16036078 |
| 122 | PRKD2 | 0.15818072 |
| 123 | ADRBK1 | 0.15494981 |
| 124 | LRRK2 | 0.15203161 |
| 125 | PAK6 | 0.14986030 |
| 126 | MAPKAPK2 | 0.13853261 |
| 127 | MAPK7 | 0.12174331 |
| 128 | MAP3K1 | 0.10059469 |
| 129 | STK11 | 0.09958016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.55433906 |
| 2 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.49250321 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.28267676 |
| 4 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.14062053 |
| 5 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.95553596 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.65578360 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 3.08870039 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.00670091 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.97190038 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.71811304 |
| 11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.58636344 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.32528745 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.28719689 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.08383286 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.04473143 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.00867142 |
| 17 | Huntingtons disease_Homo sapiens_hsa05016 | 1.90934310 |
| 18 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.86971942 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.67198188 |
| 20 | * Viral myocarditis_Homo sapiens_hsa05416 | 1.53885777 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.36442989 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.34403783 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.19578746 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.16796337 |
| 25 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.08625336 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08389564 |
| 27 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06625762 |
| 28 | Insulin resistance_Homo sapiens_hsa04931 | 1.05150172 |
| 29 | Lysine degradation_Homo sapiens_hsa00310 | 1.00907940 |
| 30 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.98643684 |
| 31 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.97131684 |
| 32 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.91987760 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.91357429 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.90410641 |
| 35 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.90036285 |
| 36 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.87852640 |
| 37 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.83413170 |
| 38 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.82824754 |
| 39 | Focal adhesion_Homo sapiens_hsa04510 | 0.82680102 |
| 40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.81719561 |
| 41 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.80806763 |
| 42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75701673 |
| 43 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.72232795 |
| 44 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.71247834 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.67463200 |
| 46 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.66982807 |
| 47 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65955726 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.64891567 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.63098770 |
| 50 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.62269283 |
| 51 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.62265517 |
| 52 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61941377 |
| 53 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60516811 |
| 54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.55472839 |
| 55 | Melanogenesis_Homo sapiens_hsa04916 | 0.55407612 |
| 56 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.54732138 |
| 57 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52873207 |
| 58 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.52454075 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 0.50641842 |
| 60 | Morphine addiction_Homo sapiens_hsa05032 | 0.50417094 |
| 61 | Insulin secretion_Homo sapiens_hsa04911 | 0.50088240 |
| 62 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.50008675 |
| 63 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.49990946 |
| 64 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.47558860 |
| 65 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47139153 |
| 66 | Amoebiasis_Homo sapiens_hsa05146 | 0.47134970 |
| 67 | * Tight junction_Homo sapiens_hsa04530 | 0.45379706 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44230631 |
| 69 | Adherens junction_Homo sapiens_hsa04520 | 0.43986209 |
| 70 | GABAergic synapse_Homo sapiens_hsa04727 | 0.43752218 |
| 71 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.43513061 |
| 72 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42978064 |
| 73 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.42009643 |
| 74 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.41722288 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41597694 |
| 76 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41198766 |
| 77 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.40723862 |
| 78 | Peroxisome_Homo sapiens_hsa04146 | 0.40217949 |
| 79 | Cocaine addiction_Homo sapiens_hsa05030 | 0.39428692 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.38795780 |
| 81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37269711 |
| 82 | Circadian entrainment_Homo sapiens_hsa04713 | 0.36078118 |
| 83 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.32535250 |
| 84 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.32206383 |
| 85 | Mineral absorption_Homo sapiens_hsa04978 | 0.31503102 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26499660 |
| 87 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.26270756 |
| 88 | Pathways in cancer_Homo sapiens_hsa05200 | 0.25156693 |
| 89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24794986 |
| 90 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.24638131 |
| 91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.24110519 |
| 92 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.23251016 |
| 93 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.22760293 |
| 94 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.22366372 |
| 95 | Gap junction_Homo sapiens_hsa04540 | 0.21111573 |
| 96 | Taste transduction_Homo sapiens_hsa04742 | 0.20732620 |
| 97 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.20711581 |
| 98 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.20640569 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.20064513 |
| 100 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.19819549 |
| 101 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.19413889 |
| 102 | Bile secretion_Homo sapiens_hsa04976 | 0.19261536 |
| 103 | Metabolic pathways_Homo sapiens_hsa01100 | 0.18932416 |
| 104 | Platelet activation_Homo sapiens_hsa04611 | 0.18592693 |
| 105 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.18421296 |
| 106 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.17130956 |
| 107 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.16551381 |
| 108 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.16411851 |
| 109 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.15509612 |
| 110 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.13663044 |
| 111 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.11131607 |
| 112 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.10242669 |
| 113 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.10205461 |
| 114 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.09912066 |
| 115 | Circadian rhythm_Homo sapiens_hsa04710 | 0.06663796 |
| 116 | Salivary secretion_Homo sapiens_hsa04970 | 0.06257091 |
| 117 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.05967134 |
| 118 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.04545943 |
| 119 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.03663306 |
| 120 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.03524288 |

